KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Gross Margin (2016 - 2025)

Charles River Laboratories International has reported Gross Margin over the past 17 years, most recently at 74.93% for Q4 2025.

  • Quarterly results put Gross Margin at 74.93% for Q4 2025, up 11114.0% from a year ago — trailing twelve months through Dec 2025 was 54.68% (up 1638.0% YoY), and the annual figure for FY2025 was 85.65%, up 2755.0%.
  • Gross Margin for Q4 2025 was 74.93% at Charles River Laboratories International, up from 59.39% in the prior quarter.
  • Over the last five years, Gross Margin for CRL hit a ceiling of 210.64% in Q4 2021 and a floor of 36.22% in Q4 2024.
  • Median Gross Margin over the past 5 years was 47.66% (2021), compared with a mean of 60.88%.
  • Biggest five-year swings in Gross Margin: plummeted -16548bps in 2022 and later skyrocketed 11114bps in 2025.
  • Charles River Laboratories International's Gross Margin stood at 210.64% in 2021, then tumbled by -79bps to 45.16% in 2022, then soared by 52bps to 68.57% in 2023, then crashed by -153bps to 36.22% in 2024, then soared by 307bps to 74.93% in 2025.
  • The last three reported values for Gross Margin were 74.93% (Q4 2025), 59.39% (Q3 2025), and 43.33% (Q2 2025) per Business Quant data.